Literature DB >> 23417241

Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent's University Hospital, Dublin (2009-2011).

F O'Kelly1, A Z Thomas, D Murray, P Lee, R F O'Carroll, P Nicholson, H Forristal, N Swan, D Galvin, D Mulvin, D M Quinlan.   

Abstract

BACKGROUND: Recent evidence has suggested that the introduction of rapid access prostate cancer programs has led to a more streamlined pathway for patients, and was designed to ultimately reduce referral delays. AIMS: To identify the initial impact of the introduction of the rapid access prostate clinic on Gleason grading within the prostate cancer cohort, as well as the impact of distance from a tertiary referral center on subsequent Gleason grading.
METHODS: A prospective database was maintained from those men attended the rapid access prostate clinic in St. Vincent's University Hospital. Data relating to demographics, biopsy results, retrospective PSA readings, and subsequent treatment pathways were all recorded and analyzed. Statistical significance was taken at p<0.05.
RESULTS: Prospective data from the rapid access prostate clinic illustrated similar results in patient demographics, Gleason grade and choice of treatment outcomes to other published institutions, however, for the first time demonstrate emerging evidence of the effect of the rapid access prostate clinic leading to a downward shift in Gleason grade over a 2-year period, as well as data showing an inverse correlation between leading Gleason grade and distance from our tertiary referral center.
CONCLUSION: These results suggest that the introduction of the rapid access prostate clinic has initially begun to demonstrate an initial downgrading in Gleason scoring patterns. Our data also reflects a poorer Gleason score in those patients living further away from the rapid access prostate clinic. This may be in part attributed to a surge in referrals of those patients previously managed outside a tertiary institution, and suggests that patients should undergo prompt referral following suspicion for prostate cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23417241     DOI: 10.1007/s11845-013-0920-3

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  9 in total

Review 1.  Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature.

Authors:  Fred Saad; Antonio Finelli; George Dranitsaris; Larry Goldenberg; Scott Bagnell; Martin Gleave; Neil Fleshner
Journal:  Can J Urol       Date:  2006-06       Impact factor: 1.344

2.  Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines.

Authors:  F J Drummond; A-E Carsin; L Sharp; H Comber
Journal:  Ir J Med Sci       Date:  2009-06-27       Impact factor: 1.568

3.  Age-specific reference ranges for serum PSA.

Authors:  J E Oesterling
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

4.  Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients.

Authors:  Jordan A Holmes; William R Carpenter; Yang Wu; Laura H Hendrix; Sharon Peacock; Mark Massing; Anna P Schenck; Anne-Marie Meyer; Kevin Diao; Stephanie B Wheeler; Paul A Godley; Karyn B Stitzenberg; Ronald C Chen
Journal:  J Urol       Date:  2012-01-15       Impact factor: 7.450

5.  A rapid access diagnostic clinic for prostate cancer: the experience after one year.

Authors:  J C Forde; K M O'Connor; L Casey; M O'Brien; S Bowen; R G Casey; I Ahmed; T E McDermott; R Grainger; T H Lynch
Journal:  Ir J Med Sci       Date:  2011-02-04       Impact factor: 1.568

6.  Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993.

Authors:  F D Gilliland; D F Gleason; W C Hunt; N Stone; L C Harlan; C R Key
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

7.  Screening for prostatic carcinoma with prostate specific antigen.

Authors:  M K Brawer; M P Chetner; J Beatie; D M Buchner; R L Vessella; P H Lange
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

8.  Time to treatment of prostate cancer through the Calgary Prostate Institute rapid access clinic.

Authors:  Alex G Kavanagh; Jay C Lee; Bryan Donnelly
Journal:  Can J Urol       Date:  2008-04       Impact factor: 1.344

9.  Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study.

Authors:  Paraskevi Panagopoulou; Helen Gogas; Nick Dessypris; Nikos Maniadakis; George Fountzilas; Eleni Th Petridou
Journal:  Eur J Epidemiol       Date:  2012-10-20       Impact factor: 8.082

  9 in total
  2 in total

1.  The effect of Rapid Access Prostate Clinics on the outcomes of Gleason 7 prostate cancer: does earlier diagnosis lead to better outcomes?

Authors:  M P Broe; J C Forde; M S Inder; D J Galvin; D W Mulvin; D M Quinlan
Journal:  Ir J Med Sci       Date:  2017-03-09       Impact factor: 1.568

2.  The effect of a Rapid Access Prostate Cancer Clinic on prostate cancer patient and disease characteristics, primary treatment and surgical workload.

Authors:  S F Oon; I M Cullen; D Moran; E M Bolton; T McDermott; R Grainger; T H Lynch
Journal:  Ir J Med Sci       Date:  2013-08-08       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.